| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.6B | $23.1B | $23.1B | $22.1B | $4.8B | $4.5B | $4.1B | $4.1B |
| Cost of Revenue | $12.1B | $11.9B | $12.3B | $12.8B | $11.4B | $9.7B | $9.9B | $10.1B |
| Gross Profit | $11.5B | $11.2B | $10.8B | $9.3B | $1.9B | $2.1B | $1.9B | $1.7B |
| R&D Expense | — | — | — | — | — | — | — | $0.1B |
| SG&A Expense | $7.7B | $7.4B | $7.1B | $6.0B | $5.6B | $5.5B | $5.3B | $5.0B |
| Operating Income | — | — | $4.2B | $3.4B | $3.1B | $3.4B | $2.8B | $2.6B |
| Net Income | $2.6B | $2.7B | $2.4B | $2.0B | $0.3B | $0.4B | $0.2B | $0.1B |
| EPS (Basic) | $10.37 | $10.68 | $9.35 | $7.83 | $1.17 | $4.54 | $2.71 | $1.09 |
| EPS (Diluted) | $10.26 | $10.55 | $9.25 | $7.72 | $1.15 | $4.46 | $2.66 | $1.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.9B | $23.6B | $23.0B | $22.6B | $20.7B | $20.4B | $20.5B | $19.1B |
| Current Assets | $6.0B | $5.4B | $5.5B | $5.9B | $5.1B | $4.6B | $4.6B | $4.3B |
| Cash & Equivalents | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.9B | $6.8B | $6.6B | $6.0B | $5.7B | $4.6B | $4.5B | $4.3B |
| Stockholders' Equity | $4.6B | $4.1B | $3.7B | $3.1B | $2.4B | $3.6B | $4.1B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.5B | $3.2B | $3.5B | $1.9B | $2.2B | $3.4B | $2.3B | $1.9B |
| Investing Cash Flow | $-2.1B | $-1.2B | $-1.0B | $-1.6B | $-0.5B | $-0.3B | $-0.5B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.4B | $-2.0B | $-2.4B | $-0.3B | $-1.8B | $-3.0B | $-1.8B | $-1.7B |